[Enteropathy due to clofazimine treatment. A case report with an ultrastructural study].
The authors report a case of enteropathy due to clofazimine treatment for prurigo nodularis. The drug usually restricted to the treatment of leprosy has sometime been given to patients suffering from skin diseases because of its assumed anti-inflammatory effects. When high dosage of clofazimine treatment is carried on during a long period, and drug accumulates in the tissues and precipitates as a solid. This crystal storage in the lamina propria of the jejunal mucosa and in the mesenteric lymph nodes accounts for an enteropathy, sometime severe but slowly regressing after drug withdrawal. The electron microscopic study shows the prints of these crystals in autophagic vacuoles of histiocytes.
D002991:Clofazimine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007579:Jejunal Diseases / Q000139:chemically induced* / Q000473:pathology; D008198:Lymph Nodes / Q000648:ultrastructure; D008206:Lymphatic Diseases / Q000139:chemically induced* / Q000473:pathology; D008643:Mesentery / Q000473:pathology; D008854:Microscopy, Electron; D008875:Middle Aged; D012871:Skin Diseases / Q000188:drug therapy
D002991:Clofazimine
Entéropathie à la clofazimine. Une observation avec étude ultrastructurale.